Mannkind (MNKD) Non Operating Income (2010 - 2026)

Mannkind (MNKD) reported Non Operating Income of -$14.7 million for Q1 2026, down 69.42% year-over-year from -$48.1 million in Q1 2025, and down 163.52% quarter-over-quarter from $23.1 million in Q4 2025.

Mannkind (MNKD) Non Operating Income (2010 - 2026) Analysis & Trends

Mannkind (MNKD) has 17 years of Non Operating Income data on file, last reported at -$14.7 million in Q1 2026.

  • Non Operating Income for Q1 2026 came in at -$14.7 million, down 69.42% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.0 million (down 149.72% YoY), and the FY2025 annual result was -$1.0 million, down 3253.12% from the prior year.
  • Non Operating Income fell to -$14.7 million in Q1 2026 per MNKD's latest filing, from $23.1 million in the prior quarter.
  • Over five years, Non Operating Income peaked at $24.1 million in Q4 2024 and troughed at -$19.3 million in Q4 2023.
  • A 5-year average of -$3.2 million and a median of -$4.7 million in 2022 frame the typical range for Non Operating Income.
  • The sharpest annual moves came in 2022 and 2023: Non Operating Income sank 24582.86% in 2022, then surged 253.62% in 2023.
  • A 5-year view of Non Operating Income shows it stood at $105000.0 in 2022, then sank by 18520.0% to -$19.3 million in 2023, then jumped by 224.35% to $24.1 million in 2024, then slipped by 3.78% to $23.1 million in 2025, then sank by 163.52% to -$14.7 million in 2026.
  • Business Quant data shows MNKD's Non Operating Income at -$14.7 million in Q1 2026, $23.1 million in Q4 2025, and -$11.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 5.75 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 444,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - 9.35 Mn
10 Mannkind 1.21 Bn 1.08 Bn 82.66 Mn -14.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.70 Mn
Dec 31, 2025 23.14 Mn
Sep 30, 2025 -11.12 Mn
Jun 30, 2025 -4.36 Mn
Mar 31, 2025 -8.68 Mn
Dec 31, 2024 24.05 Mn
Sep 30, 2024 110,000.00
Jun 30, 2024 -18.30 Mn
Mar 31, 2024 -5.83 Mn
Dec 31, 2023 -19.34 Mn
Sep 30, 2023 318,000.00
Jun 30, 2023 -6.99 Mn
Mar 31, 2023 111,000.00
Dec 31, 2022 105,000.00
Sep 30, 2022 -207,000.00
Jun 30, 2022 -8.57 Mn
Mar 31, 2022 -4.74 Mn
Dec 31, 2021 -33.66 Mn
Sep 30, 2021 1,000.00
Jun 30, 2021 35,000.00